Pasar al contenido principal

Artículos científicos publicados por los investigadores del Barcelonaβeta Brain Research Center (BBRC), relacionados con la enfermedad de Alzheimer, neuroimagen, memoria y enfermedades neurodegenerativas, entre otros campos.

Padayachee ER, Zetterberg H, Portelius E, Borén J, Molinuevo JL, Andreasen N, Cukalevski R, Linse S, Blennow K, Andreasson U. Cerebrospinal fluid-induced retardation of amyloid β aggregation correlates with Alzheimer's disease and the APOE ε4 allele. Brain Res. 2016 Nov 15;1651:11-16

Ritchie, C. W., Molinuevo, J. L., Truyen, L., Satlin, A., Van der Geyten, S., Lovestone, S., & European Prevention, A. s. (2016). Development of interventions for the secondary prevention of Alzheimer's dementia: the European Prevention of Alzheimer's Dementia (EPAD) project. Lancet Psychiatry, 3, 179-186

Rojas, S., Herance, J. R., Gispert, J. D., Arias, B., Miquel, I., Lopez, R., Sanchez, P., Rincon, E., & Murat, J. . Characterization of the Biodistribution and Systemic Absorption of TT-173, a New Hemostatic Agent of Recombinant Human Tissue Factor, Using Radiolabeling with 18F. Eur J Drug Metab Pharmacokinet, 2016

Sánchez-Benavides G, Peña-Casanova J, Casals-Coll M, Gramunt N, Manero RM, Puig-Pijoan A, Aguilar M, Robles A, Antúnez C, Frank-García A, Fernández-Martínez M, Blesa R; NEURONORMA Study Team. One-Year Reference Norms of Cognitive Change in Spanish Old Adults: Data from the NEURONORMA Sample. Arch Clin Neuropsychol. 2016 Jun;31(4):378-88. doi: 10.1093/arclin/acw018

Sanchez-Benavides, G., Gispert, J. D., Fauria, K., Molinuevo, J. L., & Gramunt, N. (2016). Modeling practice effects in healthy middle-aged participants of the Alzheimer and Families parent cohort. Alzheimers Dement (Amst), 4, 149-158

Shakeri M, Lombaert H, Datta AN, Oser N, Létourneau-Guillon L, Lapointe LV, Martin F, Malfait D, Tucholka A, Lippé S, Kadoury S; Alzheimer's Disease Neuroimaging Initiative. Statistical shape analysis of subcortical structures using spectral matching. Comput Med Imaging Graph. 2016 Sep;52:58-71. doi: 10.1016/j.compmedimag.2016.03.001

Suarez-Calvet, M., Kleinberger, G., Araque Caballero, M. A., Brendel, M., Rominger, A., Alcolea, D., Fortea, J., Lleo, A., Blesa, R., Gispert, J. D., Sanchez-Valle, R., Antonell, A., Rami, L., Molinuevo, J. L., Brosseron, F., M., & Haass, C., et al. (2016). sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers. EMBO Mol Med, 8, 466-476

Van Eldik LJ, Carrillo MC, Cole PE, Feuerbach D, Greenberg BD, Hendrix JA, Kennedy M, Kozauer N, Margolin RA, Molinuevo JL, Mueller R, Ransohoff RM, Wilcock DM, Bain L, Bales K. The roles of inflammation and immune mechanisms in Alzheimer's disease. Alzheimers Dement (N Y). 2016 May 30;2(2):99-109

Vradenburg, G., Doody, R., Fontoura, P., Molinuevo, J. L., & Zetterberg, H. (2016). Building pace and scale in the fight against alzheimer's: the road to 2025 and beyond. Neurobiol Aging, 39, S31-S31

Arbizu, J., Garcia-Ribas, G., Carrio, I., Garrastachu, P., Martinez-Lage, P., & Molinuevo, J. L. (2015). Recommendations for the use of PET imaging biomarkers in the diagnosis of neurodegenerative conditions associated with dementia: SEMNIM and SEN consensus. Rev Esp Med Nucl Imagen Mol, 34, 303-313